Health Catalyst, a leader in data and analytics technology for healthcare organizations, has acquired Carevive, a portfolio company of Debiopharm Innovation Fund. Carevive specializes in integrating patient-reported outcomes with electronic health records (EHR) data and evidence-based guidelines to enhance cancer care management. This acquisition enables Carevive to leverage Health Catalyst’s advanced technology, poised to make significant strides in cancer research and patient outcome improvements. Debiopharm Innovation Fund has been supporting Carevive since 2020, underscoring its commitment to transforming cancer care pathways and leveraging real-world data for clinical development.

Healthcare, Data and Analytics,USA, Global